Harsanyi Zsolt
Insider CIK 1380184 · EBS Chairman, Director · APVO Board of Directors, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 400 | — | — | 400 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2026-04-30 | 2026-05-04 | 11,296 | — | $0 | 11,296 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2026-04-30 | 2026-05-04 | 25,344 | — | $0 | 149,076 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2025-08-06 | 2025-08-08 | 7,200 | — | $0 | 7,200 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-07-17 | 2025-07-21 | 1 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-07-17 | 2025-07-21 | 1 | — | $0 | 1 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2025-04-30 | 2025-05-02 | 15,824 | — | $0 | 41,572 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2025-04-30 | 2025-05-02 | 34,403 | — | $0 | 123,732 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2024-07-17 | 2024-07-19 | 925 | — | $0 | 925 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-06-02 | 2024-06-03 | 81 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-06-02 | 2024-06-03 | 81 | — | $0 | 280 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-06-01 | 2024-06-03 | 7 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-06-01 | 2024-06-03 | 7 | — | $0 | 199 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 25,748 | — | $0 | 25,748 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2024-05-23 | 2024-05-28 | 17,430 | — | $0 | 89,329 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-08-09 | 2023-08-10 | 3,571 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-08-09 | 2023-08-10 | 3,571 | — | $0 | 8,475 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-06-02 | 2023-06-02 | 3,571 | — | $0 | 3,571 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-06-01 | 2023-06-02 | 297 | — | $0 | 298 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-06-01 | 2023-06-02 | 297 | — | $0 | 4,904 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-05-25 | 2023-05-30 | 33,847 | — | $0 | 71,899 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 3,571 | — | $0 | 3,571 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2022-06-01 | 2022-06-03 | 298 | — | $0 | 595 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2022-06-01 | 2022-06-03 | 298 | — | $0 | 4,607 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-05-26 | 2022-05-31 | 8,446 | — | $0 | 38,052 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 2,678 | — | $0 | 2,678 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 893 | — | $0 | 893 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-05-20 | 2021-05-24 | 5,027 | — | $0 | 29,606 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-08-17 | 2020-08-18 | 6,609 | $133.71 | $883.7K | 24,579 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 170 | — | $0 | 170 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 1,322 | — | $0 | 1,322 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,785 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 892 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,339 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-02 | 2021-02-17 | 3,571 | — | $0 | 3,571 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2020-05-21 | 2020-05-26 | 2,821 | — | $0 | 31,188 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2020-05-14 | 2020-05-18 | 3,434 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2020-05-14 | 2020-05-18 | 3,434 | $18.64 | $64.0K | 28,367 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-05-11 | 2020-05-13 | 4,940 | $81.99 | $405.0K | 24,933 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-03-16 | 2020-03-17 | 6,400 | $65.00 | $416.0K | 29,873 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2020-01-16 | 2020-01-17 | 3,435 | $55.00 | $188.9K | 36,273 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-06-07 | 2019-06-07 | 50,000 | $0.78 | $39.0K | 50,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-06-01 | 2019-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2019-05-23 | 2019-05-28 | 5,736 | — | $0 | 39,708 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-11-06 | 2018-11-08 | 8,000 | $68.90 | $551.2K | 33,972 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-06-01 | 2018-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-05-24 | 2018-05-24 | 4,895 | — | $0 | 41,972 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-12-07 | 2017-12-11 | 7,000 | $42.47 | $297.3K | 37,077 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2017-05-25 | 2017-05-26 | 8,259 | — | $0 | 44,077 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 18,750 | — | $0 | 18,750 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other deriv | 2016-08-01 | 2017-05-26 | 301 | — | $0 | 3,434 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2016-08-01 | 2017-05-26 | 577 | — | $0 | 35,818 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2016-08-01 | 2017-05-26 | 152 | — | $0 | 34,637 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2016-08-01 | 2017-05-26 | 604 | — | $0 | 35,241 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-25 | 2016-05-26 | 6,267 | — | $0 | 3,133 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-25 | 2016-05-26 | 4,800 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-25 | 2016-05-26 | 6,267 | $42.41 | $265.8K | 34,485 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-25 | 2016-05-26 | 6,267 | $20.44 | $128.1K | 40,752 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-25 | 2016-05-26 | 4,800 | $42.41 | $203.6K | 34,485 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-25 | 2016-05-26 | 4,800 | $14.25 | $68.4K | 39,285 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-24 | 2016-05-26 | 7,200 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-24 | 2016-05-26 | 2,400 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-05-24 | 2016-05-26 | 7,200 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-24 | 2016-05-26 | 7,200 | $16.13 | $116.1K | 41,685 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-24 | 2016-05-26 | 2,400 | $42.34 | $101.6K | 34,485 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-24 | 2016-05-26 | 2,400 | $14.66 | $35.2K | 36,885 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-24 | 2016-05-26 | 7,200 | $42.26 | $304.3K | 34,485 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-05-24 | 2016-05-26 | 7,200 | $22.02 | $158.5K | 41,685 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-24 | 2016-05-26 | 7,200 | $42.26 | $304.3K | 34,485 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2016-05-19 | 2016-05-23 | 5,985 | — | $0 | 34,485 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2015-05-21 | 2015-05-21 | 9,400 | — | $0 | 28,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-05-12 | 2015-05-14 | 2,400 | — | $0 | 4,800 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-05-12 | 2015-05-14 | 4,800 | — | $0 | 2,400 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-05-12 | 2015-05-14 | 13,600 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-05-12 | 2015-05-14 | 4,800 | $30.01 | $144.0K | 19,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-05-12 | 2015-05-14 | 4,800 | $14.66 | $70.4K | 23,900 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-05-12 | 2015-05-14 | 13,600 | $30.09 | $409.2K | 19,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-05-12 | 2015-05-14 | 13,600 | $11.67 | $158.7K | 32,700 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-05-12 | 2015-05-14 | 2,400 | $30.01 | $72.0K | 19,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-05-12 | 2015-05-14 | 2,400 | $14.25 | $34.2K | 21,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2014-11-25 | 2014-11-25 | 8,000 | — | $0 | 13,600 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2014-11-25 | 2014-11-25 | 8,000 | $11.67 | $93.4K | 27,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2014-11-25 | 2014-11-25 | 8,000 | $24.82 | $198.6K | 19,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2014-05-22 | 2014-05-23 | 9,400 | — | $0 | 9,400 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2014-05-22 | 2014-05-23 | 4,700 | — | $0 | 19,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2013-05-23 | 2013-05-24 | 7,200 | — | $0 | 7,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2013-05-23 | 2013-05-24 | 3,600 | — | $0 | 14,400 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2012-05-17 | 2012-05-21 | 7,200 | — | $0 | 7,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2012-05-17 | 2012-05-21 | 3,600 | — | $0 | 10,800 | SEC↗ |